Article

Oncology on Canvas and The Hope Murals Project Reaches New York City

For the 10th anniversary of the Oncology on Canvas art competition, Lilly Oncology and the National Coalition for Cancer Survivorship created The Hope Murals Project, a traveling exhibit throughout the U.S.

For the 10th anniversary of the Oncology on Canvas art competition, Lilly Oncology and the National Coalition for Cancer Survivorship created The Hope Murals Project. The project allows anyone who has been affected by cancer to help paint a series of murals developed by artists who have previously submitted artwork to the competition. To date, the contest has had more than 4,500 applicants.

"This year, to celebrate the lives and the journeys and the stories that have been shared with us, we embarked on The Hope Murals Project," says Andrew Wiersma, of Lilly Oncology. "We are painting 10 murals in 10 cities across the United States and Puerto Rico." New York City marks the ninth stop of the tour, where the art exhibit and mural painting project were housed at Grand Central Terminal.

"We started the city tour earlier this year in Anaheim, Calif., at the Oncology Nursing Society convention at ONS, and we're going to end in two weeks in Tampa, Florida," Wiersma says. Beginning in 2015, hundreds of art submissions from this year's competition will begin touring the country at various hospitals, cancer centers and patient advocacy events.

[Watch "Oncology on Canvas Winner's Cancer Experience Shapes Her Artwork"]

Related Videos
Image of Dr. Fakih.
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Image of Doctor with blonde hair.
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Image of Dr. Goy.
Image of bald man.